An article in The Buffalo News discusses how UB spinoff company Garwood Medical Devices is advancing its medical device, which was based on research by Mark Ehrensberger.

The Buffalo News profiled UB spinoff company Garwood Medical Devices, which has raised more than $14 million and “has a chance to be the next hot Buffalo startup.”

Buffalo Business First reports that UB spinoff company Garwood Medical Devices closed on a $4 million round of Series C funding to support the pre-clinical development of its BioPrax technology, which treats infections on metallic orthopaedic implants.

A story in the Buffalo News on the University at Buffalo’s new $7 million downtown incubator includes a quote from biomedical engineering PhD alumna Mary Canty, who is the lead scientist at Garwood Medical Devices, a company that has licensed technology developed at UB.

The medical device trade websites, Mass Device and Medical Design & Outsourcing, report that UB spinoff company Garwood Medical Devices has received a $749,000 federal grant to evaluate if its BioPrax medical device can prevent, control, and eliminate bacterial biofilm infections associated with orthopedic implants.